Holen Sie sich die Stockscreener-App
22.48
2.60%
0.57
Schlusskurs vom Vortag:
$21.91
Offen:
$22.21
24-Stunden-Volumen:
24,588
Relative Volume:
0.68
Marktkapitalisierung:
$N/A
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
+4.27%
1M Leistung:
-0.71%
6M Leistung:
-7.63%
1J Leistung:
+0.54%
1-Tages-Spanne:
$22.13
$22.49
1-Wochen-Bereich:
$21.79
$22.49
52-Wochen-Spanne:
$21.52
$25.80
Ishares Genomics Immunology And Healthcare Etf Stock (IDNA) Company Profile
Firmenname
Ishares Genomics Immunology And Healthcare Etf
Sektor
Branche
Telefon
-
Adresse
-
Vergleichen Sie IDNA mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
IDNA
Ishares Genomics Immunology And Healthcare Etf
|
22.48 | 0 | 0 | 0 | 0 | 0.00 |
|
VTI
Vanguard Total Stock Market Etf
|
299.14 | 417.53B | 0 | 0 | 0 | 0.00 |
|
SPY
Spdr S P 500 Etf Trust
|
603.05 | 372.57B | 0 | 0 | 0 | 0.00 |
|
IVV
Ishares Core S P 500 Etf
|
605.70 | 253.41B | 0 | 0 | 0 | 0.00 |
|
VB
Vanguard Small Cap Etf
|
252.64 | 160.59B | 0 | 0 | 0 | 0.00 |
|
QQQ
Invesco Qqq Trust Series 1
|
524.80 | 124.43B | 0 | 0 | 0 | 0.00 |
Ishares Genomics Immunology And Healthcare Etf Aktie (IDNA) Neueste Nachrichten
Bird Flu Sparks Vaccine Stock Surge: ETFs To Watch As H5N1 Outbreak Intensifies - Benzinga
7 Best-Performing Biotech ETFs for January 2025 - NerdWallet
Future Health: Harnessing Innovations In Healthcare - Syfe
Thematic Portfolios Re-optimisation – Capturing Emerging Trends and Maximising Growth Potential - Syfe
The Healthcare Sector: 5 Things To Know - Syfe
Top ETFs Tracking CRISPR Gene Editing - The Motley Fool
7 Best Biotech ETFs In Canada for January 2025 - Wealth Awesome
iShares Genomics Immunology and Healthcare ETF (ARCA:IDNA) Quotes, Forecast and News Summary - Benzinga
iShares Genomics Immunology and Healthcare ETF declares semi-annual distribution of $0.1114 - MSN
BlackRock® Canada Announces June Cash Distributions for the iShares® ETFs - Yahoo Finance
IDNA ETF: Healthcare Dashboard For February - Seeking Alpha
Top Thematic ETF Ideas for 2024: AI & More - Yahoo Canada Finance
Has Biotechnology Bottomed Out? - Master Investor
2024 Market Forecast: 3 Key Trends in the Healthcare Industry - InvestorPlace
3 Healthcare Technology Stocks to Improve Lives in 2024 - InvestorPlace
IDNA ETF: Continues To Underperform, But With Long Run Potential - Seeking Alpha
Megatrends: Gene Therapy and Editing - U.S News & World Report Money
StockWatch: Top Biotech ETFs (Mostly) Sink Faster than the Market During Q1 - Genetic Engineering & Biotechnology News
The 7 Best Biotech ETFs to Buy for Exposure to the Healthcare Sector - Yahoo Finance
7 Monkeypox Vaccine Stocks to Buy Before They Shoot Higher - InvestorPlace
Noticeable performance for Healthcare and Biotech ETFs - Trackinsight
Biotech ETFs Slip After Novavax Cuts 2022 Guidance - ETF Trends
RBC iShares Opens the Market - Canada NewsWire
ETF Battles: ARKG Vs IDNA Vs GNOM - Yahoo Finance
Why ETFs may be the best way to bet on the future of biotech - The Globe and Mail
3 Biotech ETFs That Could Double Your Money by 2025 With Zero Effort - The Motley Fool
iShares Genomics Immunology And Healthcare ETF, Overshadowed But Not Irrelevant (NYSEARCA:IDNA) - Seeking Alpha
Go Beyond Trends: Healthcare Megatrends and IDNA - ETFdb.com
Genomics ETFs Surge on CRISPR's Gene Editing Progress - Zacks Investment Research
Why megatrend ETFs offer long-term growth potential - ETF Strategy
BlackRock dives deeper into thematic ETFs: Fund Scan - Financial Planning
iShares Launches Megatrend ETF Suite Designed to Capture Five Transformational Long-Term Trends - Business Wire
BlackRock lists genomics and cyber security ETFs - ETF Stream
Top Healthcare ETFs Right Now • Updated Daily - Benzinga
ARK Genomic Revolution ETF - ETFdb.com
Finanzdaten der Ishares Genomics Immunology And Healthcare Etf-Aktie (IDNA)
Es liegen keine Finanzdaten für Ishares Genomics Immunology And Healthcare Etf (IDNA) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
1.26%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):